SGN — Solgenics Balance Sheet
0.000.00%
Last trade - 00:00
UtilitiesHighly SpeculativeMicro Cap
- £1.08m
- £5.33m
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.614 | 0.424 | 0.722 | 0.853 | 0.9 |
Net Total Receivables | 0.083 | 0.054 | 0.026 | 0.112 | 0.074 |
Total Inventory | |||||
Total Current Assets | 0.697 | 0.478 | 0.748 | 0.965 | 0.974 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 18.3 | 18.3 | 18.3 | 18.3 | 18.4 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 19 | 18.8 | 19.8 | 20.3 | 19.6 |
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 4.62 | 5.51 | 4.67 | 6.32 | 5.87 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 4.62 | 5.51 | 4.67 | 6.32 | 5.87 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 14.4 | 13.2 | 15.1 | 14 | 13.7 |
Total Liabilities & Shareholders' Equity | 19 | 18.8 | 19.8 | 20.3 | 19.6 |
Total Common Shares Outstanding |